Although the possible application of conotoxins to treat NDD have not been researched as extensively as analgesic applications, current scientific literature produced illustrates that several diverse conotoxin families have demonstrable potential for the treatment of NDD and that conotoxins targeting both voltage-gated and ligand-gated ion channel families have potential in treatment of NDD. This evidence concerns the gene GLRA3 and Neurodevelopmental delay.